CMTM6 stabilizes PD-L1 on the surface of tumor cells by preventing its lysosomal degradation, thereby enhancing the tumor’s ability to suppress T cell-mediated immune responses in the tumor microenvironment. Here, CD274 is linked to neoplasm.